Crossmark

Mefloquine targets <scp>NLRP3</scp> to reduce lipopolysaccharide‐induced systemic inflammation and neural injury

Crossref DOI link: https://doi.org/10.15252/embr.202357101

Published Online: 2023-08-25

Published Print: 2023-10-09

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Jiang, Si‐Yuan

Tian, Tian

Li, Wen‐Jie

Liu, Ting

Wang, Cong

Hu, Gang

Du, Ren‐Hong https://orcid.org/0000-0003-2504-7406
Liu, Yang https://orcid.org/0000-0003-4243-2330
Lu, Ming https://orcid.org/0000-0001-8018-8389
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82173797)

National Natural Science Foundation of China (82273906)

National Natural Science Foundation of China (81922066)

National Natural Science Foundation of China (81991523)
License Information

Version of Record valid from 2023-08-25
More Information

Publication History

Received: 2023-03-01

Accepted: 2023-08-13

Published: 2023-08-25